![]() |
Volumn 20, Issue 5, 1999, Pages 210-217
|
Heart failure and endothelin receptor antagonists
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID;
3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID;
3 BENZYL 4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 2 BUTENOIC ACID;
4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID;
4 TERT BUTYL N [6 (2 HYDROXYETHOXY) 5 (3 METHOXYPHENOXY) 4 PYRIMIDINYL]BENZENESULFONAMIDE;
5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE;
5,6,8,13 TETRAHYDRO 1,6,9,14 TETRAHYDROXY 3 (2 HYDROXYPROPYL) 7 METHOXY 8,13 DIOXOBENZO[A]NAPHTHACENE 2 CARBOXYLIC ACID;
BOSENTAN;
CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL);
ENDOTHELIN 1;
ENDOTHELIN RECEPTOR ANTAGONIST;
L 751281;
L 754142;
N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE;
PD 14893;
RES 701 1;
SKF 66861;
TAK 044;
TTA 788;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
CELL DAMAGE;
DISEASE COURSE;
HEART FAILURE;
HEART LEFT VENTRICLE FAILURE;
HEART MUSCLE CELL;
HEART MUSCLE CONTRACTILITY;
HEART VENTRICLE HYPERTROPHY;
INOTROPISM;
LONG TERM CARE;
NONHUMAN;
PRIORITY JOURNAL;
RABBIT;
RAT;
REVIEW;
SIGNAL TRANSDUCTION;
SUDDEN DEATH;
SURVIVAL RATE;
TREATMENT PLANNING;
ENDOTHELIUM CELL;
HAMSTER;
HUMAN;
ANIMALS;
ENDOTHELIN-1;
GENE EXPRESSION REGULATION;
HEART FAILURE, CONGESTIVE;
HEMODYNAMIC PROCESSES;
HUMANS;
MYOCARDIAL CONTRACTION;
MYOCARDIAL ISCHEMIA;
RECEPTORS, ENDOTHELIN;
|
EID: 0032996418
PISSN: 01656147
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-6147(99)01297-3 Document Type: Review |
Times cited : (44)
|
References (89)
|